ARL6

Chr 3ARDigenic recessive

ARF like GTPase 6

Also known as: BBS3, RP55

The protein encoded by this gene belongs to the ARF-like (ADP ribosylation factor-like) sub-family of the ARF family of GTP-binding proteins which are involved in regulation of intracellular traffic. Mutations in this gene are associated with Bardet-Biedl syndrome (BBS). A vision-specific transcript, encoding long isoform BBS3L, has been described (PMID: 20333246). [provided by RefSeq, Apr 2016]

Primary Disease Associations & Inheritance

{Bardet-Biedl syndrome 1, modifier of}MIM #209900
ARDigenic recessive
Bardet-Biedl syndrome 3MIM #600151
AR
Retinitis pigmentosa 55MIM #613575
AR
1
Active trials
0
Pathogenic / LP
0
ClinVar variants
4
Pubs (1 yr)
0.6
Missense Z
0.92
LOEUF
Clinical SummaryARL6
🧬
Gene-Disease Validity (ClinGen)
ciliopathy · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Low constraint (pLI 0.01) — loss-of-function variants are relatively tolerated in the population.
💊
Clinical Trials
1 active or recruiting trial — potential therapeutic options may be available

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
0.92LOEUF
pLI 0.010
Z-score 1.77
OE 0.44 (0.230.92)
Tolerant

Typical tolerance to LoF variation

Missense Constraint
0.56Z-score
OE missense 0.84 (0.701.01)
81 obs / 96.3 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.44 (0.230.92)
00.351.4
Missense OE0.84 (0.701.01)
00.61.4
Synonymous OE0.96
01.21.6
LoF obs/exp: 5 / 11.5Missense obs/exp: 81 / 96.3Syn Z: 0.18
DNGOF
DN
0.78top 25%
GOF
0.72top 25%
LOF
0.2679th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

0 submitted variants in ClinVar

ARL6 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Gene2Phenotype Curations

ARL6-related Bardet-Biedl syndrome

definitive
ARLoss Of FunctionAbsent Gene Product
Dev. DisordersEye
G2P ↗

ARL6-related retinal dystrophy

strong
ARUndeterminedAbsent Gene Product, Altered Gene Product Structure
Dev. DisordersEye
G2P ↗
missense variantinframe deletioninframe insertion

Gene2Phenotype curations · DECIPHER consortium patient cohort (public variants) · deciphergenomics.org

Clinical Literature
Landmark / reviewRecent case evidence